Journal: Frontiers in Cell and Developmental Biology
Article Title: Selective Retinoic Acid Receptor γ Antagonist 7C is a Potent Enhancer of BMP-Induced Ectopic Endochondral Bone Formation
doi: 10.3389/fcell.2022.802699
Figure Lengend Snippet: Effect of RARγ agonist/antagonist on ATDC5 cells and MSCs. (A) Alcian blue staining of ATDC5 cells in micromass (scale bar = 1 mm). The blue stained area was extracted using ImageJ (version 1.52q, U. S. National Institutes of Health; https://imagej.nih.gov/ij/ ) ( n = 4 per group). (B) Quantitative RT-PCR analysis of ATDC5 cells cultured in chondrogenic medium supplemented with BMP-2 (20 ng/ml) and 7C (50 nM) or NRX (100 nM) ( n = 4 per group). (C) Alcian blue staining of MSCs in micromass (scale bar = 1 mm). The blue stained area was extracted using ImageJ ( n = 4 per group). (D) The gene expression level of Sox9 in MSCs cultured in chondrogenic medium. Sox9 expression was upregulated by 7C, even in the absence of BMP-2 ( n = 3 per group). * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001 and ns, not significant.
Article Snippet: CD2665 (RARγ antagonists, CAS 170355-78-9) and CD1530 (RARγ agonist, CAS:107,430-66-0) were purchased from Cayman Chemical Company (Ann Arbor, MI, United States).
Techniques: Staining, Quantitative RT-PCR, Cell Culture, Expressing